{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fhiv-monitoring-on-la-prep-Rx6_cD4z","width":444,"version":"1.0","type":"rich","title":"Long-Acting PrEP: Monitoring for New HIV Infection","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/4ad62396-3ed6-4471-8e09-505020c1ba83/cmoh-dn-5074-pod-2-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/3125aa71-99b8-4a0f-afbe-dfa8f3e82a1a\" height=\"200\" width=\"100%\" title=\"Long-Acting PrEP: Monitoring for New HIV Infection\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Darcy Wooten, MD, discuss the updated guideline recommendations and rationale for monitoring patients receiving LA PrEP for new HIV infection."}